Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free FRX Stock Alerts

Fennec Pharmaceuticals (FRX) Stock Chart & Stock Price History

Fennec Pharmaceuticals logo
C$12.40 0.00 (0.00%)
As of 06/11/2026
Compare

Fennec Pharmaceuticals Stock Price Performance

The Fennec Pharmaceuticals (FRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 9.35%, with a year-to-date return of 16.98%. In the past month, the stock has increased 29.44%, reflecting recent market activity.

As of the latest close, Fennec Pharmaceuticals traded at C$12.40 with a market cap of C$430.74 million and volume of 1,357 shares. Five years ago, the stock traded at C$8.22, representing a 50.85% increase over that period. At the time, it had a market cap of C$220.51 million and a volume of 1,917 shares.

Receive FRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-2.52%
1 Month
Performance
+29.44%
3 Month
Performance
+15.67%
Year-To-Date
Performance
+16.98%
1 Year
Performance
+9.35%
5 Year
Performance
+50.85%

FRX Stock Chart for Friday, June, 12, 2026

FRX Chart by TradingView

Fennec Pharmaceuticals Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
06/11/2026C$12.40C$12.40C$12.40C$11.621,357 shsC$430.74 million
06/10/2026C$12.44C$12.40
-0.32%		C$12.40C$11.621,357 shsC$430.74 million
06/09/2026C$12.44C$12.44C$12.44C$12.44519 shsC$432.13 million
06/08/2026C$12.72C$12.44
-2.20%		C$12.44C$12.44519 shsC$432.13 million
06/05/2026C$12.72C$12.72C$13.21C$12.721,030 shsC$441.86 million
06/04/2026C$12.72C$12.72C$13.21C$12.721,030 shsC$441.86 million
06/03/2026C$13.76C$12.72
-7.56%		C$13.21C$12.721,030 shsC$441.86 million
06/02/2026C$13.35C$13.76
+3.07%		C$13.76C$13.571,844 shsC$477.98 million
06/01/2026C$13.67C$13.35
-2.34%		C$13.50C$13.35409 shsC$463.74 million
05/29/2026C$13.71C$13.67
-0.29%		C$13.72C$13.551,075 shsC$474.86 million
05/28/2026C$13.88C$13.71
-1.22%		C$14.13C$13.71915 shsC$476.24 million
05/27/2026C$13.73C$13.88
+1.09%		C$14.21C$13.82860 shsC$482.15 million
05/26/2026C$13.88C$13.73
-1.08%		C$13.77C$13.404,135 shsC$476.94 million
05/25/2026C$13.69C$13.88
+1.39%		C$14.09C$13.60409 shsC$482.15 million
05/22/2026C$13.60C$13.69
+0.66%		C$14.24C$13.693,783 shsC$475.55 million
05/21/2026C$13.50C$13.60
+0.74%		C$13.60C$12.651,904 shsC$472.42 million
05/20/2026C$13.71C$13.50
-1.53%		C$13.98C$13.452,135 shsC$468.95 million
05/19/2026C$13.31C$13.71
+3.01%		C$13.71C$13.50647 shsC$476.24 million
05/18/2026C$13.31C$13.31C$13.78C$12.852,483 shsC$462.35 million
05/15/2026C$12.65C$13.31
+5.22%		C$13.78C$12.852,483 shsC$462.03 million
05/14/2026C$9.28C$12.65
+36.31%		C$13.22C$9.808,618 shsC$439.12 million
05/13/2026C$9.58C$9.28
-3.13%		C$9.63C$9.281,110 shsC$322.14 million
05/12/2026C$9.65C$9.58
-0.73%		C$9.70C$9.58373 shsC$332.55 million
05/11/2026C$9.65C$9.65C$9.65C$9.65101 shsC$334.98 million
Related Companies

This page (TSE:FRX) was last updated on 6/12/2026 by MarketBeat.com Staff.
From Our Partners
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Tesla. SolarCity. Twitter. This $4 stock is next.
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...
Behind the Markets | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The U.S. Government Just Turned Tax Dollars1 into 407% Gains
The U.S. Government has quietly built a stock portfolio that's up 278% in less than nine months - 26 times bet...
Weiss Ratings | Sponsoredtc pixel